Acta medica Iranica · 2012
Carotid body tumors: radiotherapy as an alternative approach.
Редакционная статьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Azlan Ummi Kalthum, Abd Hakim Hadi Azamuddin, Wong Pei Lou, Che Lah Noor Hanini, Zhou Chenyu, Mohammad Zamani Nur Irlia Sofea, Tong Xiaohui, Han Rongchun, Mohmad Misnan Norazlan, Sarian Murni Nazira, Rohani Emelda Rosseleena, Mediani Ahmed, Jam Faidruz Azura, Hamezah Hamizah Shahirah
Аннотация
BACKGROUND: Moringa oleifera is a medicinal plant rich in bioactive compounds. Native to Southeast Asia, it thrives in tropical climates like Malaysia. Maturity stages of M. oleifera leaves might substantially affect the effectiveness of therapy; hence, optimizing the bioactive phytoconstituents is crucial. Liquid chromatography-mass spectrometry(LC-MS)-based metabolomics is essential to (i) evaluate differences in phytochemical composition and bioactivities across leaf maturity, (ii) profile and model leaf metabolome across maturity stages using untargeted ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for key metabolites annotation, and with multivariate data analysis (MVDA) to reveal maturity-linked clusters and discriminant metabolites, and (iii) integrate multivariate regression to relate metabolite signatures to bioassays and nominate optimal maturity stages.
METHODS: M. oleifera leaves were harvested at different maturity stages (day-30, 45, and -60) from Kuala Terengganu, Malaysia. Aqueous ethanolic extracts were subjected to bioactivity assays, including total phenolic (TPC) and flavonoid contents (TFC), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ferric reducing power test (FRAP) antioxidant activity, and acetylcholinesterase (AChE) inhibition. Metabolomics profiling was conducted, and the correlation of phytochemicals to bioactivities was performed by multiple MVDA models.
RESULTS: Day-60 leaf extracts exhibited higher TPC and TFC compared to younger stages, with strong antioxidant activity as indicated by elevated DPPH and FRAP values. In contrast, AChE inhibition was highest in day-30 extracts. Metabolomics profiling with chemometrics integration using MVDA identified and tentatively annotated 27 metabolites with predominantly flavonoids (59%), phenolic acids (19%), glucosinolates (7%), and minor components including coumarins, folates, and alkaloid-like compounds. Principal component analysis (PCA) and partial least squares (PLS) biplot revealed distinct metabolic clustering, with day-60 extract formed clear separated cluster, determined by accumulation of quercetin rutinoside, chlorogenic acid, kaempferol derivatives, and procyanidin B2. PLS biplot demonstrated that quercetin derivatives, chlorogenic acid, and procyanidin B2 were positively associated with antioxidant indicator, while coumarin and folic acid aligned with AChE inhibition. Unknown metabolites indicated by chromatogram peak area with high Variable Importance in Projection (VIP) scores (>1) also contributed to bioactivity trends and separation, lead to potential of unannotated phytochemicals.
CONCLUSION: This study found that maturity stage influences the phytochemistry and bioactivities of M. oleifera leaf. Chemometrics integration of metabolomics analysis with bioassays shows that maturity stages drive distinct metabolite clustering and bioactivities, with day-60 yielding the highest phenolic, flavonoid, and antioxidant capacity (DPPH/FRAP), while day-30 exhibits the strongest AChE inhibition, thereby, defining maturity-specific optimal harvests.
METHODS: M. oleifera leaves were harvested at different maturity stages (day-30, 45, and -60) from Kuala Terengganu, Malaysia. Aqueous ethanolic extracts were subjected to bioactivity assays, including total phenolic (TPC) and flavonoid contents (TFC), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, ferric reducing power test (FRAP) antioxidant activity, and acetylcholinesterase (AChE) inhibition. Metabolomics profiling was conducted, and the correlation of phytochemicals to bioactivities was performed by multiple MVDA models.
RESULTS: Day-60 leaf extracts exhibited higher TPC and TFC compared to younger stages, with strong antioxidant activity as indicated by elevated DPPH and FRAP values. In contrast, AChE inhibition was highest in day-30 extracts. Metabolomics profiling with chemometrics integration using MVDA identified and tentatively annotated 27 metabolites with predominantly flavonoids (59%), phenolic acids (19%), glucosinolates (7%), and minor components including coumarins, folates, and alkaloid-like compounds. Principal component analysis (PCA) and partial least squares (PLS) biplot revealed distinct metabolic clustering, with day-60 extract formed clear separated cluster, determined by accumulation of quercetin rutinoside, chlorogenic acid, kaempferol derivatives, and procyanidin B2. PLS biplot demonstrated that quercetin derivatives, chlorogenic acid, and procyanidin B2 were positively associated with antioxidant indicator, while coumarin and folic acid aligned with AChE inhibition. Unknown metabolites indicated by chromatogram peak area with high Variable Importance in Projection (VIP) scores (>1) also contributed to bioactivity trends and separation, lead to potential of unannotated phytochemicals.
CONCLUSION: This study found that maturity stage influences the phytochemistry and bioactivities of M. oleifera leaf. Chemometrics integration of metabolomics analysis with bioassays shows that maturity stages drive distinct metabolite clustering and bioactivities, with day-60 yielding the highest phenolic, flavonoid, and antioxidant capacity (DPPH/FRAP), while day-30 exhibits the strongest AChE inhibition, thereby, defining maturity-specific optimal harvests.